A multicentre phase I/II study of TAS-102 with nintedanib in patients with metastatic colorectal cancer refractory to standard therapies (N-TASK FORCE: EPOC1410); Phase I results

Authors :: T. Nishina
Y. Kuboki
E. Shinozaki
S. Fukuoka
T. Kajiwara
K. Shitara
K. Yamaguchi
Y. Komatsu
S. Yuki
K. Yamazaki
H. Hara
N. Mochizuki
M. Fukutani
H. Hasegawa
S. Matsuda
M. Wakabayashi
S. Nomura
A. Sato
A. Ohtsu
T. Yoshino
Source :: Annals of Oncology. 27:vi156
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Full Text Access

Tools